Sirolimus Treatment for Refractory PRCA

Clinical trial NCT03364764 · COMPLETED

Trial details

NCT number: NCT03364764
Sponsor: Bing Han
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pure Red Cell Aplasia

Start date: 2018-02-01
Primary completion: 2019-02-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.